No scientific evidence underlines need for Covid booster dose: ICMR

But according to the government sources, the Centre is right now focusing on maximum coverage of full vaccination under the 'Har Ghar Dastak' program

A health worker administers a dose of Covid-19 vaccine to a visitor at a vaccination centre in Kolkata on October 22, 2021. (PTI Photo/ Swapan Mahapatra)
A health worker administers a dose of Covid-19 vaccine to a visitor at a vaccination centre in Kolkata on October 22, 2021. (PTI Photo/ Swapan Mahapatra)
ANI General News
2 min read Last Updated : Nov 21 2021 | 4:10 PM IST

 

New Delhi [India], November 21 (ANI): Many experts have recommended booster doses of the COVID-19 vaccine in India, especially for those with comorbidities or healthcare workers as they have already received both doses.

But according to the government sources, the Centre is right now focusing on maximum coverage of full vaccination under the 'Har Ghar Dastak' program.

Dr Samiran Panda who is the head of the Epidemiology and Infectious diseases division at the Indian Council of Medical Research (ICMR) said that right now the scientific evidence from within the country does not underline the need for a booster dose.

Speaking to ANI, Dr Panda said, "The Ministry of Health gets guided by scientific evidence and also advised by NTAGI. These are advisory bodies and considered by the Ministry and the respective departments to develop a policy. So, policy formulation and decisions are based on scientific evidence. Right now the scientific evidence from within the country does not underline the need for a booster dose. Public health considerations are on the priority now."

"If you ask me, the need of the hour is to attain 80 per cent coverage or more among the individuals with 2 doses of vaccine. Reaching out to over 80 per cent of eligible individuals is public health priority now," he said.

He also stressed focusing on the vaccination program rather than on the booster dose.

"Discussing the booster dose doesn't make sense because there are people who are you know, in hesitation to come forward for the second day thinking that So, if we discuss the booster to return to we are actually leaving the programme halfway," he added.

Dr Tamorish Kole, President of Asian Society for Emergency Medicine (ASEM), said, "When we are talking about the third dose, we must prioritise with the low level of immunity, immune-compromised such as cancer patients and patients who received an organ transplant and give them the booster dose first. So, I will urge the government to prioritise the frontline workers to give the third dose.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus VaccineICMR

First Published: Nov 21 2021 | 4:10 PM IST

Next Story